首页>
外国专利>
USE OF A TETRASUBSTITUTED PYRAZOLO4,3-DPYRIMIDINE COMPOUND FOR TREATING DIABETIC NEPHROPATHY.
USE OF A TETRASUBSTITUTED PYRAZOLO4,3-DPYRIMIDINE COMPOUND FOR TREATING DIABETIC NEPHROPATHY.
展开▼
机译:四取代吡唑并[4,3-D]嘧啶类化合物治疗糖尿病性肾病的用途。
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to methods of delaying progression to end stage renal disease (ESRD) in patients comprising administration of 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methylpyridin-2- yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carb oxamide. The present invention also includes administration of pharmaceutical compositions for delaying progression to ESRD. 1-(2-ethoxyethyl)-5-(ethyl(methyl)amino)-7-((4-methylpyridin-2- yl)amino)-N-(methylsulfonyl)-1H-pyrazolo[4,3-d]pyrimidine-3-carb oxamide.
展开▼